The U.S. Food and Drug Administration has expanded the emergency use authorization for the Pfizer-BioNTech Covid-19 vaccine to include children ages 12-to-15 years-old.That expands the Dec.
11, 2020 use authorization for people 16 and older and at the same dosage. It means a much bigger swathe of the U.S. population can be vaccinated — including middle schoolers before next September rolls around.The FDA called the expansion “a significant step in the fight against the COVID-19 pandemic.”“Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic.
Read more on deadline.com